Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1992-12-30
|
pubmed:abstractText |
Tumor-infiltrating lymphocytes (TILs) were isolated from a subcutaneous metastasis of melanoma and cytotoxic T-cell lymphocyte (CTL) lines were obtained by sensitizing in vitro four separate aliquots of TILs with autologous tumor cells and recombinant interleukin-2. All CTL lines were predominantly WT31+, CD3+, and CD8+ and displayed a preferential cytotoxic activity against the autologous tumor. T-cell receptor (TCR) composition was analyzed by using the polymerase chain reaction with 5' variable region (V alpha or V beta)-specific primers and 3' constant (C alpha or C beta) primers. The entire repertoire of the V alpha and V beta gene families tested was present in fresh TILs and in the CTL lines, although, in the latter, consistent quantitative variations in transcripts of several V alpha and V beta occurred. CTL clones that exhibited CD3-dependent and major histocompatibility complex-restricted killing of the autologous melanoma were isolated from the four TIL cultures. TCR analysis indicated that, independently from the culture of origin, only two combinations of V alpha and V beta gene families were present in the majority of these CTL clones. These V alpha and V beta gene families were not found in a panel of CTL clones that did not lyse the autologous tumor. This study indicates that recognition of melanoma antigens can strongly select for certain types of TCR-bearing T-lymphocytes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1053-8550
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
207-11
|
pubmed:dateRevised |
2008-3-18
|
pubmed:meshHeading |
pubmed-meshheading:1332745-Antigens, CD3,
pubmed-meshheading:1332745-Antigens, CD8,
pubmed-meshheading:1332745-Base Sequence,
pubmed-meshheading:1332745-Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor,
pubmed-meshheading:1332745-Gene Rearrangement, beta-Chain T-Cell Antigen Receptor,
pubmed-meshheading:1332745-Humans,
pubmed-meshheading:1332745-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:1332745-Major Histocompatibility Complex,
pubmed-meshheading:1332745-Melanoma,
pubmed-meshheading:1332745-Molecular Sequence Data,
pubmed-meshheading:1332745-Polymerase Chain Reaction,
pubmed-meshheading:1332745-Skin Neoplasms,
pubmed-meshheading:1332745-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:1332745-Tumor Cells, Cultured
|
pubmed:year |
1992
|
pubmed:articleTitle |
Expansion of major histocompatibility complex-restricted antimelanoma cytotoxic T-cell lymphocyte clones with identical T-cell receptor from tumor-infiltrating lymphocytes.
|
pubmed:affiliation |
Division of Experimental Oncology D, Istituto Nazionale Tumori, Milan, Italy.
|
pubmed:publicationType |
Journal Article
|